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A high-fat diet (HFD) has been shown to cause more hepatic lipid accumulation as 
compared to a low-fat control (C) diet. However, it is still unclear what role epigenetic 
mechanisms play in hepatic lipid accumulation. We hypothesize that a HFD will cause 
greater hepatic lipid accumulation through increased lipid synthesizing gene expression 
via decreased gene methylation. The objective of this study is to determine the role of 
methylation in hepatic lipid synthesizing genes as an outcome of hepatic lipid 
accumulation due to a HFD. Two models were used to address the following: the direct 
effects of a post-weaning HFD on hepatic lipid synthesizing genes as well as the indirect 
effects of a maternal HFD. Timed-pregnant Sprague-Dawley rats were given either a C 
(16% fat) or HFD (45% fat) during gestation and lactation. Pups from both C mothers 
were weaned onto either a C or HFD and the pups from the maternal HFD were weaned 
onto a HFD, creating three offspring groups: C/C, C/HF, and HF/HF. Model 1 compared 
the C/C group to the C/HF group, while model 2 focused on the comparison of the C/HF 
group to the HF/HF group. Rats were sacrificed at 12 weeks of age, and the left lobe of 
the liver was used for further analysis.  In model 1, liver histology showed greater hepatic 
fat accumulation in the C/HF group. Gene expression data was measured for multiple 
genes in the following pathways: glycolysis, gluconeogenesis, fatty acid synthesis, and 
triacylglycerol synthesis. Glycerol-3-phosphate acyltransferase (GPAM), fatty acid 
synthase (FASN), acetyl CoA carboxylase 1 (ACC1), and glucose-6-phosphotase 
(G6Pase) showed lower levels of mRNA in the C/HF group as compared to the C/C group. 
DNA methylation of those genes was analyzed based on data obtained from methyl-DNA 
immunoprecipitation with high-throughput sequencing (MEDIP-SEQ). Differential 
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methylation was observed for G6Pase, GPAM, and ACC1. GPAM and ACC1 showed 
decreased average methylation read peaks for C/HF in comparison to the C/C group. The 
data in model 1 suggest that decreased gene body methylation leads to decreased lipid 
synthesizing genes. In model 2, liver histology showed greater hepatic fat accumulation 
in the HF/HF group. Gene expression data were measured in the same pathways as 
previously stated. GPAM and FASN showed higher levels of mRNA in the HF/HF group. 
MEDIP-SEQ data showed greater average methylations read peaks for HF/HF along the 
gene body for GPAM. Methylation specific polymerase chain reaction (MSP) validated 
these results by showing greater methylation on intron 1, on the 7.2 kilobases (kB) pair 
region, as well as exon 21, at 59.5 kB pair region on GPAM. The data in model 2 suggest 
that increased gene body methylation leads to increased lipid synthesizing genes. These 
studies suggest that there is a positive relationship between gene body methylation and 
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Obesity has increased more than two-fold since 1980 and comes with a multitude 
of complications and problems including non-alcoholic fatty liver disease (NAFLD) [20]. 
Part of the progression of NAFLD is the accumulation of fat in the liver, and a HFD has 
been shown to increase more fat accumulation in the liver as compared to a diet that is 
low in fat [25, 23, 22]. The accumulation of fat in the liver has been associated with 
increased hepatic lipid synthesizing genes such as fatty acid synthase (FASN1), glycerol-
3-phosphate acyltransferase (GPAM), and acetyl-CoA carboxylase 1 (ACC1) [2].   
However, the epigenetic mechanisms concerning gene body methylation that 
contribute to this increased gene expression are yet to be fully understood. Current 
research has shown that an increase in gene promoter methylation leads to a decrease 
in gene expression [10]. A HFD has been shown to upregulate lipid synthesizing genes 
such as GPAM, FASN, diglyceride acyltransferase (DGAT), and 1-acylglycerol-3-
phosphate-O-acyltransferase 6 (AGPAT6) [25]. Furthermore, this increase in lipid 
synthesizing genes has been shown to increase due to early life exposure to a HFD [25]. 
In addition to a post-weaning HFD, a maternal HFD has been shown to increase fat 
accumulation [25]. A maternal HFD has also been shown to decrease gene promoter 
methylation in the triglyceride forming rate-limiting step enzyme; GPAM, in concordance 
with an increase in gene expression [6].  
It is clear that a post-weaning HFD leads to increased hepatic lipid accumulation. 
In addition, early life exposure to a HFD, by maternal diet, programs lipid synthesizing 
genes via gene promoter methylation. However, it is not clear what the role of gene-body 
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methylation is in programming hepatic lipid synthesizing genes by the effect of a HFD as 
well as early life exposure to a HFD. In order to test the role of gene body methylation in 
differential gene expression due to a HFD induced hepatic lipid accumulation, we looked 
at two models. The first model that we looked at was how a HFD  directly affects the gene 
body methylation status on various differential gene expression pathways. Due to the 
heritable nature of methylation, the second model we looked at was how a maternal HFD 
indirectly affects the gene body methylation status on the offspring’s various differential 
gene expression pathways. These studies are the first to elucidate the epigenetic 







The following is a literature review of recent research on the effects of a HFD on 
the epigenome by organ type. 
Liver 
It is clear that a HFD has an effect on methylation status in the liver. Zhang et al. 
looked at timed-pregnant Sprague-Dawley rats fed either a C or HFD (16% vs. 45% fat, 
respectively) was able to show that in rat hepatic tissue a HFD caused methylation 
differences. There were 12,494 differentially methylated regions (DMR) that were 
hypomethylated and 6,404 DMRs that were hypermethylated [23]. Even in cases where 
global DNA methylation is not changed a HFD seems to affect specific gene methylation 
[13]. Pacana et al. were able to show that in the absence of global DNA methylation a 
high fat and high cholesterol diet reduced DNA methyltransferase (Dnmt3a) in female 
C57BL/6 mice. HMG-CoA reductase, which is the rate-limiting enzyme in cholesterol 
production was found to be hypermethylated at CpG sites on the promoter. This would 
be expected as the high cholesterol diet would reduce the need for de novo cholesterol 
synthesis [13].  
Promoter methylation of hepatic genes seems to be the most effected by a HFD. 
Also, a maternal HFD continues this effect into offspring [6]. Ehara et al. showed that in 
the livers of 5-day old mice pups whose maternal and paternal diets were a high fat and 
sucrose diet, expression of glycerol-3-phosphate acyltransferase (GPAT1) was 
increased. This increase in GPAT1 expression was associated with a decrease in its gene 
promoter methylation [6].  
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In addition to promoter methylation, a HFD affects hepatic gene expression via 
histone modification. Strakovsky et al. fed obesity resistant timed pregnant Sprague 
Dawley rats a HFD from embryonic day 2 until embryonic day 20 where they collected 
liver from offspring after caesarean delivery. The mRNA and pre-mRNA expression of 
phosphoenolpyruvate carboxykinase (Pck1) was higher in the liver of the HFD offspring. 
G6Pase, Cebpalpha, Srebp1a and Pgc1a mRNA content was higher in the HFD offspring. 
At the Pck1 promoter, there was decreased H3Ac, H3K4Me2, H3K9Me3, and H3K27Me3 
in the HFD offspring. In the coding region, there was increased H4Ac and H3K4Me2, but 
lower H3K9Me3 in the HFD offspring. In the 5 kB upstream region, there was increased 
H4Ac and H3K4Me2 in the HFD offspring [17]. While observing the male offspring, they 
saw significantly increased hepatic triglyceride content, but not in the female HFD group 
[18]. However, hepatic non-esterified fatty acid content was decreased in the HFD group 
offspring. Male HFD offspring had higher Pon1 and Pon3 mRNA expression. Both male 
and female had higher Pon2 mRNA expression in the HFD offspring. There was also 
higher Sod2 mRNA expression in male HFD offspring. However, the acetylation at H4 at 
the promoter for both male and female was increased. H3K4Me2 was also increased in 
male and female HFD offspring at the promoter [18]. 
Interestingly, Suter at al saw a decrease in H3K9Me3 and H3K14Ac in fetal liver 
collected at embryonic day 18.5 [19]. They looked at CD1 female mice, which were 
maintained on a C or HFD (9% vs. 35.5% respectively) for two weeks before mating with 
Glut 4 (G4) +/-  and wild type males. They were on their respective diets throughout 
gestation and lactation. The offspring were weaned onto a low-fat diet (4.5% fat) at 
postnatal day 21.  When looking at offspring at 5 weeks, this trend continued for the HFD 
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group. They saw that for the 5-week HFD group, Sirt 1 had significantly decreased; as 
Sirt1 deacetylates H3K14. Since they looked at CD1 wild type (WT) mice and Glut 4 
knockouts, only the WT group showed a significant reduction in gene expression of 
Histone Acetyltransferase (Gcn) 5, Histone Deacetylase (Hdac) 1 and Hdac3. They 
performed ChIP-on-ChIP to determine the localization of H3K14Ac and H3K9Me3. They 
looked only at the fetal liver and observed robust enrichment in a broad region 
surrounding the transcription start site in each of the 8 groups that were studied. They 
used ChIP-on-chip to determine if there were any genetic differential enrichment between 
C vs. HFD. They saw 454 genes in the WT and 755 genes in the G4+/- that were altered 
significantly for both H3K14Ac and H3K9Me3. H3K14ac is enriched differentially in 
regions that contain Gata1, 2, and 4 and Myf5 binding motifs. H3K9me3 is enriched 
differentially in regions that contain GFY, E2F, E2F4, and RUNX-AML binding motifs. 
They generated gene lists using ingenuity pathway analysis (IPA) to determine which 
biologic networks are represented differentially. Four genes that are involved in lipid 
metabolism consistently emerged as central convergence nodes for the differentially 
represented pathways, which are: Pparg, Ppara, Rora, and Rxra. For each of these four 
genes, both the WT and G4+/- had H3K14ac and H3K9me3 enrichment in the HFD fetal 
liver. They used primers proximal to the TSS. Only Pparg mRNA was increased in the 
G4+/- HFD fetal liver. Indeed, H3K14Ac and H3K9Me3 are enriched in the promoter of the 
Pparg of only the G4+/- [19].  
Furthermore, looking at the effects of a long term HFD on acetylation Mikula et al. 
looked at C57Bl/6J mice with a leptin gene mutation [11]. At six weeks of age, one group 
was fed a C diet (10% fat) and another a HFD (60% fat), until 16 weeks or 48 weeks. 
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Higher Tumor necrosis factor alpha (Tnfa) and Monocyte chemotactic protein 1 (Ccl2) 
mRNA in both 16 and 48 weeks in the liver of ob/ob and HFD-fed mice. Steatosis and 
mild inflammation were observed in the old HFD-fed mice and the young and old ob/ob 
mice. Neither polymerase II or NF-kB was increased for either Tnfa and Ccl2. In fact, in 
Ccl2 there was less pol II. The acetylation at H3K9K18 at the first and last exon of Tnfa 
was increased in the obese mice but not significant in Ccl2. The trimethylation of histone 
H3 lysine 4 (H3K4me3) is regarded as an indicator of active chromatin at the 5’ ends of 
actively transcribed genes, but they saw no change of this in the obese mice for Tnfa. 
The first exon of Ccl2 had significantly less of this in obese mice, which is contrary to what 
you would expect based on the mRNA results. The trimethylation of histone H3 lysine 36 
is associated with transcription elongation and is expected to gradually increase toward 
the 3’ end of a transcribed gene. They saw no change in the Tnfa for obese mice, but 
mirrored the same results for H3K4me3 in Ccl2 for obese mice. They then looked into cell 
culture on mouse liver cells where they stimulated inflammation by treatment with 
Lipopolysaccharide (LPS). They then checked for the expression of Tnfa and Ccl2, which 
was increased. Then they checked for Pol2 levels in both exon 1 and the last exon and 
saw that it was increased for both genes. This was the same for Nuclear factor NF-kB. 
The peak expression of the pol II and NF-kB was at 90 minutes after LPS activation, and 
this was also the peak levels for H3K9K18Ac, at both the first and last exons, which is 
how they showed that the histone modification is causing the increase in Tnfa and Ccl2 
gene expression. They were able to show that histone modification, mainly acetylation at 
H3K9K18 at the first and last exons, leads to increase gene expression due to the 
potential inflammatory effect of a HFD [11].  
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In contrast to an increase in acetylation, Yang et al. looked at the effects of a 
maternal high fat diet on the fetal liver [22]. They looked at 80 day old Sprague-Dawley 
rats, which were acclimated on standard chow for 1 week, before mating and going on 
either a HFD (45% fat) or a C diet (16% fat) throughout gestation and lactation. Rat livers 
were collected postnatal day 7. They saw decreased mRNA expression of Wnt1 in HFD 
offspring as compared to C and decreased nuclear b-catenin protein in female HFD rats. 
They also saw a significant decrease in H4Ac at the Wnt1 promoter in HFD rats, while in 
the coding region, there was a decrease in H3Ac and an increase in H3K9Me3 in the HFD 
rats [22]. 
Zhou et al. looked at Sprague-Dawley rats 10-12 weeks old, with either 16% fat or 
45% fat throughout gestation and lactation [25]. After 21 days pups were weaned onto a 
C diet for 12 weeks before livers were collected. Interestingly, they saw many sex-specific 
differences. They saw an increase in the mRNA and pre-mRNA of Pepck in maternal HFD 
group for females but a decrease in males. FASN was increased in a female while Dgat 
and Agpat6 decreased. Gpam increased in male liver, while Cpt-1a decreased. They also 
saw an increase in transcription factor Cebpb in the female. Transcription factors Cebpa 
and Pgc1a decreased in male liver. Ash1l for H3K4Me3 and Suv39h2 for H3K9Me3 were 
increased for the maternal HFD group. In female maternal HFD group, promoter pol II 
binding was increased, and there was a significant decrease of H3K9Me3 but an increase 
in H3K27Me3. They plotted a line graph of different histone modifications while measuring 
protein abundance of pepck compared to changes along the 5’ upstream to the 3’ 
downstream region of pepck. For H3K4Me2 there was an increase at the -2kB, -1kB, 
+1kB, +3kB, +5kB, and +7kB. For H3K4Me3 there was an increase at +1kB and +3kB. 
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For H3K9Me3 and H3K27Me3 there was an increase at the promoter, while H3Ac was 
increased at +1kB. This data shows that both methylation of K4 and acetylation of H3 are 
positively associated with Pepck expression in a region-specific manner [25]. 
Cao et all was able to show that menin plays an essential role in hepatic lipid 
accumulation [3]. They bred menin knockout (KO) mice and showed that even at a young 
age, exposure to a C diet lead to 10% heavier livers in the menin knockout mice compared 
to the C mice. As the mice aged, hepatic lipid accumulation only accelerated, eventually 
showing a 40% increase as compared to the C mice. While analyzing hepatic genes 
related to lipid metabolism, they found that CD36, involved in fat storage, was the most 
significantly elevated. CD36 was also shown to increase in the livers of aging C mice. 
This intersecting point between fatty liver and aging was the foundation of their rationale 
to move forward into their next experiment where they bred Men1flox/flox mice with mice 
expressing the Cre recombinase driven by the albumin promoter. Heterozygous Men1f/+-
Cre+ mice were backcrossed with C57BL/6J mice 5 times, then crossed to generate 
hepatocyte-specific Men1 knockout mice (Men1f/f –Cre+), with their C mice (Men1f/f –Cre-
). After 8 weeks, mice were then fed on their respective diets for 14 weeks (HFD vs C). 
They used HEK293T cells to show that endogenous menin could be pulled down by 
SIRT1 or vice versa. Using truncated flag-menin constructs to map the binding sites of 
SIRT1 they showed that the N-terminus, C-terminus, leucine zipper-like motif deletions 
and the middle part of menin could bind to SIRT1. This is important as SIRT1 is a primary 
histone deacetylase. If menin typically recruits SIRT1 to the promoter of CD36 to down-
regulate its expression then losing this regulation may lead to over-acetylation on the 
promoter of CD36 thus leading to the overexpression of CD36. In order to check for this, 
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they isolated primary hepatocytes from the menin KO and C mice and used ChIP to look 
at the promoter region of CD36, in which they used 7 different primers that cover around 
400 bp each on the promoter. In the C mice, they saw that the CD36 promoter had a 
binding of SIRT1 and menin. In the menin knockout mice, they saw that the 1710-1246 
bp, 1338-875 bp, 1425-1085 bp, and 568-166 bp of upstream regions of the promoter 
showed reduced SIRT1 binding and increased H3 acetylation. Their mechanism showed 
that the loss of menin lead to increased CD36 expression since SIRT1 was not brought 
to the promoter by menin. This data shows that hepatic lipid accumulation may occur by 
increased promoter acetylation of CD36 due to the HFD reducing menin expression and 
SIRT1 recruitment [3]. 
These data show that a HFD can affect histone modification by increasing or 
decreasing acetylation and methylation. However, whether it is increased or decreased 
directly varies along different genes, gene location, and regulatory pathways. Although 
the data does not reach a clear consensus on the direction of the effects of a HFD on 
histone modification, it is clear that histone modification is mechanistically used to affect 
hepatic gene expression.  
Adipose Tissue 
 
Multhaup et all looked at the methylation status in adipose tissue [12]. They 
examined male C57BL/6 mice at 4 weeks of age that were fed either a HFD or a C diet 
for 12 weeks. Using comprehensive high throughput array or CHARM, 232 differentially 
methylated regions (DMRs) correlated with diet status. They found hypermethylation on 
the promoter of Phosphoenol-pyruvate carboxykinase 1, a rate limiting enzyme in 
gluconeogenesis. The genome wide DMRs were near genes that were significantly 
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overrepresented in lipid metabolism and immune/inflammatory pathways. Interestingly, 
the DMRS that were hypermethylated seem to be near enriched genes of metabolism, 
while the hypomethylated regions were near enriched genes of inflammation. They saw 
a trend of an inverse correlation of gene expression to gene methylation. Out of 625 
significant mouse adipocyte DMRs, 576 of those DMRs had homologous regions in the 
human genome, and 497 of the DMRs were conserved. Of the 497 conserved DMRs 249 
of those were significantly different in obese vs. lean humans. They also showed that the 
main mechanism for methylation-mediated metabolic dysfunction is likely through 
epigenetic enhancer modification. They showed that 40.6% and 14.7% of the directionally 
consistent 170 regions and 53.3% and 20% of the further 30 genome wide associated 
study for type 2 diabetes-associated regions were positioned in adipose enhancers and 
super enhancers, respectively [12]. 
These changes in methylation status in mouse adipocytes lead them to check 
human adipocytes. They utilized cell culture of samples from 7 lean, 16 obese and 8 
obese post Roux-en-y gastric (RGYB) subjects to look at the effects of gene regulation 
implicated in obesity, type 2 diabetes, and insulin resistance. They looked at 5 genes that 
they saw had methylation reversal from RGYB bypass surgery, but that had no prior 
association with metabolic phenotypes. They then either upregulated or knock-downed 
these genes to mimic hypo and hyper methylation in high fat fed adipocytes, respectively. 
4 out of the 5 genes that were either knocked out or over-expressed significantly altered 
glucose uptake. This shows that although these genes have not previously been 
associated with metabolic phenotypes, the method to look at methylation changes in 
concordance with phenotypic changes due to interventions like RGYB bypass surgery, 
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may be a good way to understand the mechanism of how a HFD can cause insulin 
resistance, obesity, and type 2 diabetes [12].  
Xia et al. looked more specifically at promoter methylation for the gene leptin [21]. 
They looked at male C57BL/6J mice at 3 to 4 weeks of age, which were given either a 
60% fat HFD or a 10% fat C diet up to 18 weeks. They were able to establish 16 CpG 
sites in the leptin promoter in c57 mouse epididymal fat. They found, on average, more 
methylated promoter DNA at 12 weeks and 18 weeks of a HFD compared to the earlier 
weeks and the C diet group methylation; thus, leading to reduced leptin production from 
adipose tissue [21].  
Not only does methylation affect the promoter of leptin in adipose tissue due to a 
HFD but Shen et al. was able to elucidate a role of acetylation in this pathway [15]. They 
used 3 to 4-week-old C57BL/6J mice and put them on three different diets (HFD 60% fat 
kcal, HFD 60% fat w/ n-3 PUFA, and LFD 10% fat kcal) after 1 week of acclimation. They 
stayed on their respective diets for 14 weeks. Interestingly, they saw higher levels of 
plasma leptin in the HFD mice compared to C. 9 out of 16 CpG sites in the leptin promoter 
were more methylated in the HFD mice compared to the C, which seems to contradict the 
direction of the current literature. Three of those CpG sites are specific for the binding of 
the transcription factors SP1 and Lp1. There were significantly higher levels of DNA 
Methyl-transferase (DNMT) 1, DNMT3a, DNMT3b, and MBD2 at the leptin promoter in 
the HFD mice. Naturally, they saw less pol II binding at this promoter. At the promoter of 
leptin, there was significantly fewer levels of H3Ac, H4Ac for the HFD group. It is 
interesting to note that compared to Cao et al.’s work this is in direct contradiction as they 
showed increased acetylation on the CD36 promoter leads to increased expression of it; 
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here Shen et al. shows the opposite effect [3, 15]. There was also the higher binding of 
HDAC1, HDAC2, and HDAC6. They saw significantly fewer levels of H3K4Me at the leptin 
promoter for the HFD group. The average of the methylation for the 16 CpG’s on the 
promoter of leptin proved to be less at 8 weeks but higher at 12 and 18 weeks in the HFD 
diet group. They also showed two correlation graphs: Increased mRNA expression of 
leptin was correlated with increased promoter methylation in the HF group and decreased 
mRNA expression of leptin in C group was correlated with decreased promoter 
methylation [15]. 
Fan et al. used a HFD mouse model to analyze DMRs [7]. They showed that 24 
promoters were hypermethylated and 42 were hypomethylated in epididymal fat tissue 
that overlapped with transcriptionally expressed genes. They also showed that with genes 
that have high CpG sites within the promoter, a negative correlation exists between 
transcriptional expression and methylation. However, they did not see this correlation with 
genes that have an intermediate or low amount of CpG sites within the promoter. They 
saw that the genes that were hyper-methylated and under-expressed were relevant to 
metabolic processes such as lipid metabolism, type 2 diabetes, obesity linked pathways, 
etc. The reverse of that was also true; genes that were hypomethylated and 
overexpressed also were linked to metabolic processes. In the three genes examined, 
Mmp2, Foxj3, and Ube2q2, increased average promoter methylation levels were found in 
Foxj3 and Ube2q2 but significantly less in the Mmp2 promoter. The gene expression data 
showed an inverse relationship with promoter methylation [7].  
Interestingly, although most studies show the inverse relationship between 
promoter methylation and gene expression, with Shen et al.’s study seeming to be an 
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outlier; Gracia et al.’s study may provide some corroboration in support of Shen et al.’s 
study [8, 15]. They looked at the adipose tissue of male Wistar rats fed an obesogenic 
diet at 45% fat. When observing the promoter of FASN in the HFD group, they saw 
hypomethylation in the -90bp position and hypermethylation in the -62bp position 
compared to C diet rats. This pattern of methylation resulted in a fivefold increase gene 
expression for the HFD after 6 weeks. This is a case where different positions within the 
promoter have different outcomes on gene expression. It is possible that the -90 bp CpG 
position has a more relevant role in the expression of FASN or as Shen et al.’s study 
suggest; a role for methylation in the promoter for increased gene expression [8, 15].  
 
Brain, Blood, Muscle & Colon 
 
Cifani et al. examined male Sprague Dawley rats fed a HFD with either obese 
resistant (DR) or obese prone (DIO) groups [5]. They looked at promoter methylation in 
NPY, PPARy, and POMC in hippocampal tissue. On the NPY promoter, they found an 
increase in methylation on the 5th CpG site for the DR group, which carried its effect into 
transcriptional gene expression as there was a significant decrease in NPY mRNA. They 
found increased methylation on POMC promoter at 21 weeks in the DR group compared 
to the DIO group. This is interesting due to the anorexigenic properties of the POMC gene, 
as we would expect to see less promoter methylation in the DR group. However, despite 
increased promoter methylation, they did see increased mRNA levels of POMC. In this 
study, increased promoter methylation seems to be positively associated with an increase 
in the mRNA levels of POMC, yet negatively associated in the case of NPY [5].  
Zheng et al. looked at a mouse model with a maternal high fat and high sucrose 
(FS) diet with either a FS or C diet in the offspring. Maternal FS combined with FS 
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offspring diet showed increased expression of POMC and MC4R in the hypothalamus. 
Looking at DNA methylation in the hypothalamus, differential methylation patterns 
emerged between FS-FS and C groups. There was hypomethylation of the POMC 
promoter in the high-fat offspring which is positively associated with POMC gene 
expression. However, methylation did not seem to be the epigenetic mechanism that 
explained the increased expression of MC4R. This study seems to follow the trend in the 
literature showing an inverse relationship between promoter methylation and gene 
expression and in direct contradiction to Cifani et al.’s study showing a positive 
relationship between POMC promoter methylation and gene expression [5, 24].  
Marco, Kisliouk, Tabachnik, Meiri & Weller raised Wistar female rats on either a 
HFD or a C diet and at post-natal day (PND) 80 they sacrificed half the rats and bred the 
other half with male Wistar rats [9]. After pregnancy at post-natal day 22, they sacrificed 
the dams. They also sacrificed female pups at PND 22 and then raised the rest until PND 
80 on a C diet. At PND 80 they sacrificed females and put the rest of the rats on a 30 day 
HFD. HFD-C pups weighed more at P22 and ate more kcals/day. The HFD-C compared 
to the C-C group weighed more throughout their lifetime and weighed more during the 30 
day HFD challenge that was presented at the end of their trial: HFD-C-HFD weighed more 
than the C-C-HFD. In the nulliparous female rats, although they were higher in body 
weight after 2 months of HFD they did not have higher levels of pomc mRNA. Despite 
having more leptin, their pomc/leptin ratio was still lower compared to the C diet group. 
They found more methylation at three specific sites on the Pomc promoter in the HFD 
group as compared to the C group. At the end of lactation, they saw a weight decrease 
in both groups, but the HFD group still weighed more. This loss in weight was seen in 
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concordance with both groups showing similar levels of pomc and leptin mRNA. The 
promoter methylation of pomc between both groups was similar. This methylation data 
was similar to Cifani et al in that there was increased POMC promoter methylation in the 
HFD group [5, 9]. However, this did not correspond to increased gene expression. When 
they looked at the hypothalamic arcuate nuclei of the HFD group, they saw that POMC 
promoter hypermethylation was correlated with decreased POMC expression. Here, the 
inverse relationship of the POMC promoter methylation to gene expression is further 
established [9]. 
Sanchez, Reynoso-Camacho & Salgado looked at the blood of male and female 
Wistar rats fed either a HF and high fructose diet or a C diet [14]. They crossed MaleHFD 
x FemaleHFD, MaleHFD x FemaleControl and MaleControl x FemaleHFD at two different time 
points (24 & 36 weeks), which then were divided between the two different diets. They 
looked specifically at global methylation in peripheral blood leukocytes of the parental 
animals. When looking at the change in methylation over time, they saw that between the 
males and females there were differential responses. In males, the HFD induced 
methylation that was lower compared to C, and although methylation increased over time, 
it was always lower than the C group. In females, a HFD induced higher methylation as 
compared to their C counterparts. They then looked at the whole blood of the offspring 
(F1) and saw that compared to their parents (F0) only the females fed the C diet showed 
increased methylation as compared to the F0 at the 12-week time point. Other than that, 
there were no differences between generations. They concluded that there was a positive 
association between methylation and metabolic syndrome symptoms [14]. Although they 
were not able to establish any specificity in intragenic methylation this does provide 
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evidence that increased global methylation may be an indicator of metabolic 
dysregulation.  
Amaral et al. looked specifically into mouse gastrocnemius tissue of mice fed a 
HFD, omega-3 supplementation or both [1]. Hepatic peroxisome proliferator-activated 
receptor gamma transcript variant 2 (Pparg2) mRNA increased due to a HFD and 
decreased with fish oil supplementation. Although the HFD group had almost a 6-fold 
increase in Pparg2, promoter methylation showed no differences. In the gastrocnemius 
muscle, the HFD group showed increased global DNA methylation along with decreased 
Pparg2 gene expression. Interestingly, when looking at promoter methylation for Pparg2, 
there was decreased methylation at the -247 bp CpG. Interestingly, these data showed a 
positive correlation with promoter hypomethylation and decreased gene expression [1].  
Choi, Tammen, Liu & Friso examined how a HFD vs. aging affects global DNA 
methylation patterns [4]. In mouse colon, they found decreased DNA global methylation 
patterns due to a HFD but not due to aging. They observed promoter specific DNA 
methylation changes due to both effects, but only the HFD caused a global DNA 
methylation response. Of importance, the p16 promoter had more methylation in both 
aging and HFD groups. This is of significance since the p16 promoter is commonly 
methylated in colon cancer cases. This study corroborates Sanchez, Reynoso-Camacho 
& Salgado’s study in that HFD increases global methylation that leads to deleterious 
effects [4, 14].  
 After thoroughly reviewing the effects of a HFD on epigenetics in multiple organs; 
the majority of the studies seem to establish an inverse relationship between promoter 
methylation and gene expression. However, there were a few studies of interest that 
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showed an opposite effect and may provide some evidence to a possible positive 
correlation between promoter methylation and gene expression in certain genes or CpG 
sites. Although a clear pattern in gene expression directionality was not confirmed for 
histone modification, it is clear that a HFD affects histone modification with the outcome 
of differential gene expression. Lastly, it is important to note that although we saw much 
promoter methylation data and a few studies on global methylation data, it is unclear what 
the effects of gene body methylation have on gene expression as well as how a HFD 






MATERIALS & METHODS 
Animals 
Timed-pregnant Sprague Dawley rat dams (Charles River Laboratories, 
Wilmington, MA) were fed either a standard AIN93G C diet (Research Diets, Inc.; 16% 
calories from fat) or a diet high in fat (HF; Research Diets, Inc.; 45% calories from fat) 
during gestation and lactation. Dams were individually housed with their pups in standard 
polycarbonate cages in a humidity- and temperature-controlled room on a 12-hour light-
dark cycle with ad libitum access to food and drinking water [23]. On postnatal day 21, 
male offspring were divided into three groups: one group was kept on the same C diet 
(C/C, n=7) as C diet dams, the other group was kept on the same HFD as the HFD dams 
(HF/HF, n=8), and the last group switched to a HFD from the C diet dams (C/HF, n=8) 
(Figure 3-1). Male offspring were fed their respective diets for 9 weeks, at which time 
animals were sacrificed and the median lobe of the liver was immediately frozen in liquid 
nitrogen and stored at -70°C. Institutional and governmental regulations regarding the 
ethical use of animals were followed during the study. The protocol for ethical use of 
animals for this study was approved by the University of Illinois Institutional Animal Care 
and Use Committee (IACUC protocol no. 09112). 
 
Liver Histology 
 Frozen liver samples comparing C/C and C/HF were embedded in Tissue-Tek 
OCT compound (VWR, Radnor, PA, USA) and cut to a thickness of 7 µm in a cryostat at 
-20°C for model 1 and 5 µm for model 2. All sections were fixed in 10% ice cold formalin 
for 5 minutes and then stained with Oil Red O (ORO) solution. Images were obtained by 
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the NanoZoomer Slide Scanner and NDP View software (Hamamatsu, Bridgewater, NJ, 
USA). ORO images were quantified using ImageJ software and statistically compared 
with standard T-Test on Microsoft Excel.  
Frozen liver samples comparing C/HF and HF/HF were embedded in Tissue-Tek 
OCT compound (VWR, Radnor, PA, USA) and cut to a thickness of 5 μm in a cryostat at 
−20°C. All sections were fixed in 70% ethanol and then stained with hematoxylin and 
eosin (H&E) or Oil Red O (ORO) solution. Images were obtained by NanoZoomer Slide 
Scanner and NDP View software (Hamamatsu, Bridgewater, NJ, USA). All images were 
analyzed by two unbiased observers who were blinded to the identity of the samples. The 
observers were asked for their input on intensity, and the figures show representative 
images of samples from both groups. The fatty liver damage scale was used to quantify 
liver damage and ranges from 1-5, with healthy liver scored between 1.5-2. 
 
MEDIP-SEQ and MRE-SEQ 
Genomic DNA isolation was performed according to previously published methods 
[23]. Next generation sequencing was performed on one animal from each of the C/C, 
C/HF, and HF/HF groups. Gene expression and histology were measured in each animal, 
and the best representative from each group was chosen for sequencing. Methylation 
was measured using methylated DNA immunoprecipitation (MEDIP-SEQ) and 
methylation-sensitive restriction enzyme (MRE). MEDIP-SEQ utilizes antibodies against 
5mC to quantify methylated DNA sequences while MRE-seq uses restriction enzymes 
that cut at unmethylated CpG sites. Run together, MEDIP-SEQ and MRE-SEQ improve 
coverage and resolution [32, 33]. The laboratory of Dr. Ting Wang at the University of 
Washington St. Louis, MO used previously established protocols to run the high 
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throughput sequencing [34,35]. Subsequently, bioinformatics analysis was performed in 
Dr. Yuan-Xiang Pan’s lab at the University of Illinois.  
 
DMR identification 
All MEDIP-SEQ sequences were aligned to the rn4 rat genome assembly with 
Burrows-Wheeler Aligner (BWA) and processed using methylQA [31]. Average 
methylation read peaks were selected by the following criteria: ³ 50% higher methylation 




Validation of DNA methylation was performed on hepatic tissue from all animals 
using methylation-specific PCR (MSP). Genomic DNA was isolated from hepatic tissue 
using the DNeasy Tissue Kit (Qiagen) and was treated with sodium bisulfite reagent using 
the EZ Methylation- Gold kit (Zymo Research). Bisulfite converted DNA samples were 
diluted to 10 ng/ul for quantitative PCR analysis. A standard curve was generated by 
pooling two 20 ng/ul DNA samples from each group performing a 1:2 serial dilution for a 
total of 8 points. Primer Express Software 3.0.1 (Applied Biosystems) was used to design 
primers for quantitative PCR. Four primers were designed for each DMR of interest. 
Forward and reverse primers amplified the bisulfite converted DMR sequences that were 
either methylated (containing protected CpG) or unmethylated (containing thymines in 
place of all cytosines). Primers had a melting temperature (Tm) of 58-60 °C and contained 
minimal predicted hairpins, self-dimers, and heterodimers. Primers were between 22 and 
38 nucleotides, and the total amplicon size was between 72 and 225 bp.  
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The PCR was performed using a 96-well plate with a final reaction volume of 10 
μl. Each reaction contained 5 μl of Power SYBR® Green Master Mix (Life Technologies), 
2.2 μl of nuclease-free water, and 0.4 μl of 5 μM each of the forward and reverse primers. 
The reaction was as follows: 95 °C for 15 min followed by 45 cycles of 95 °C for 15 s and 
60 °C for 1 min (Applied Biosystems, StepOnePlus real-time PCR system). The relative 
amounts of methylated and unmethylated DNA were analyzed based on their respective 
standard curves. Percentage of methylated DNA was calculated with the following 
equation: % of methyl DNA= (relative quantity of methylated DNA) / (relative quantity of 
methylated DNA + quantity of unmethylated DNA) 
 
Gene expression 
Total RNA was obtained using 50 mg of liver tissue digested in TRIzol® Reagent 
(Life Technologies) followed by Direct-zol™ RNA MiniPrep columns (Zymo Research) 
with in-column DNase I digestion for RNA isolation. RNA concentration and purity were 
measured using Nanodrop 2000 (Thermo Fisher Scientific). Reverse transcription was 
performed using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) 
and incubated in the 2720 Thermal Cycler (Applied Biosystems) using the following 
protocol: 25°C for 10 min, 37°C for 2 h and 85°C for 5 s. Following reverse transcription, 
a standard curve was generated by serial dilution of four pooled samples. cDNA samples 
were amplified using Power SYBR® Green Master Mix (Life Technologies) in a 
StepOnePlus™ Real-Time PCR System (Life Technologies). The inclusion of a melting 
curve ensured purity of the PCR product. All reported mRNA quantities are normalized to 
a geometric mean of Actb and Rpl7a gene expression.	 	
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Chapter 4 
HIGH FAT DIET CAUSES HEPATIC LIPID ACCUMULATION BY PROGRAMMING 








Hepatic lipid accumulation tested by Oil Red-O staining showed greater hepatic 
lipid accumulation in the C/HF group as compared to the C/C group. Percent area 
measured between the two groups showed a significantly higher percentage of area 
covered by fat in the C/HF group at around 17.5% compared to only 7% in the C/C group 








We did not see any differences in PEPCK, but we did see a decrease in G6pase 
in the C/HF group as compared to the C/C. We did not see any differences in FBP1 (Table 
4-1).  
 
Fatty Acid Synthesis 
 
 
When looking at the fatty acid synthesis pathway, we did see multiple genes 
differentially expressed. Specifically, in the C/HF group, both ACC1 and FASN were 




Furthermore, we saw an increase in the lipid storage gene GPAM but not AGPAT6 




 When looking at the MEDIP-SEQ data for ACC1 and GPAM, we see that there is 
indeed differential methylation between C/C and C/HF (Figures 4-2 – 4-7). Unlike 
previous studies, the mRNA expression data were not correlated with the promoter 
methylation pattern of both ACC1 and GPAM as we did not see any significant differences 
between the groups. However, in the absence of differential promoter methylation, we did 
see 12 greater average methylation read peaks along the gene body of ACC1 in the C/C 
group with only three greater average methylation read peaks for the C/HF group (Figures 
4-2 – 4-5). We see that at the following positions along the gene body of ACC1 there was 
greater average methylation read peaks for the C/C group: +13.5 kB, +14 kB, +26 kB 
(Exon 5), +33 kB, +33.5 kB (Exon 8), +65.5 kB, +68.5 kB, +75.5 kB (Exon 24) +76.5 kB 
(Exon 25), +133.5 kB (Exon 40), +153 kB, +170 kB, and +194 kB (3’ Downstream Region) 
(Figures 4-3 – 4-8). We saw that at the following positions along the gene body of ACC1 
there was greater average methylation read peaks for the C/HF group: +117 kB, +122 kB 
and +127 kB (Figures 4-2 – 4-5). Comparatively, the data suggest that the C/C group has 
greater overall methylation along the gene body and 3’ downstream region. When looking 
into the methylation patterns along GPAM, we saw a similar trend compared to the 
methylation pattern we observed along ACC1. There are no differences in promoter 
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methylation; however, we see seven greater average methylation read peaks for the C/C 
group and only two greater average methylation read peaks for the C/HF group (Figures 
4-6 – 4-7).  We saw that at the following positions there was greater average methylation 
read peaks for the C/C group: +4 kB, +10.5 kB, +22 kB, +28 kB, +32.5 kB, +40 kB (Exon 
8), and +43 kB (Exon 9). We saw that at the following positions there was greater average 
methylation read peaks for the C/HF group: +5 kB & +47.5 kB (Exon 13) (Figures 4-6 – 
4-7). The methylation pattern along the gene body of GPAM follows the same pattern that 





Oil Red-O staining showed greater hepatic lipid accumulation in the HF/HF group as 
compared to the C/HF group. The liver structure was tested using H&E staining and 
showed greater hepatic vacuolation in the HF/HF group as compared to the C/HF group 
(Figure 4-8). Comparing gradation on the fatty liver damage scale the C/HF group scored 
a 3, while the HF/HF group scored a 4.5.  
 
Gene Expression 
Fatty Acid Synthesis 
When comparing the C/HF group to the HF/HF group, we observed more FASN in 






When considering the comparison between the C/HF group and the HF/HF group 
we saw a similar pattern in the lipogenesis trend in model 1 as GPAM was differentially 
expressed (Table 4-1). However, in this case the group that had greater hepatic lipid 




When looking at the MEDIP-SEQ data for GPAM between C/HF and HF/HF, it is 
clear that we see differential methylation between the two groups. Similar to the first 
model, we see no differences in promoter methylation but rather along the gene body. 
The HF/HF group has greater gene body methylation overall, as we see four separate 
greater average methylation read peaks and only one peak greater in the C/HF group. 
We see that at the following positions along the gene body of GPAM there was greater 
average methylation read peaks for the HF/HF group: +10.5 kB, +12 kB, +41 kB, and 
+56.5 kB. In comparison, only the following two peaks showed greater average 
methylation reads for the C/HF group: +10 kB and +53.5 kB (Exon 19) (Figures 4-9 & 4-
10). These data suggest that in the HF/HF group there is greater gene body methylation.  
 
MSP 
 In order to validate the MEDIP-SEQ data, we used MSP to check for methylation 
at specific locations along the gene body and 3’ downstream region. We checked six 
different locations along the gene body and 3’ downstream region, and although all six 
locations showed greater levels of methylation for the HF/HF group, the following two 
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locations showed significantly higher levels for the HF/HF group: Intron 1 +7200 kB and 
Exon 21 +59500 kB (Figure 4-11).  
 
Discussion  
In these studies, we attempt to understand how methylation is involved in the gene 
expression of hepatic lipid synthesizing genes due to hepatic lipid accumulation by a HFD. 
To investigate the role of methylation we looked at two different hepatic lipid accumulating 
models. The first model we looked at was the effects of a post-natal HFD on the 
methylation status of hepatic lipid synthesizing genes. Male Sprague-Dawley rats were 
exposed to either a HFD or C diet for nine weeks. We then collected liver samples and 
ran qRT-PCR to check for differences in multiple metabolic pathways including glycolysis, 
gluconeogenesis, fatty acid synthesis, and triacylglycerol synthesis. We found differences 
in mRNA expression for the gluconeogenic, fatty acid synthesis and the triacylglycerol 
synthesis pathways. Of those pathways, there were four major enzymes that we found to 
be differentially expressed. For the gluconeogenic pathway, the enzyme G6Pase was 
decreased in the C/HF group. For the fatty acid synthesis pathway, we found two 
enzymes that were decreased in the C/HF group: ACC1, which is the rate-limiting step in 
fatty acid production and FASN. Lastly, in the triacylglycerol synthesis pathway, we found 
the rate-limiting enzyme, GPAM, to be decreased in the C/HF group. Upon further 
inspection of the methylation status on ACC1 and GPAM, we found differential 
methylation patterns along the gene body. In order to more comprehensively understand 
the role of methylation, we looked into a second model, which addresses the heritability 
of methylation. The second model we looked into were the effects of a maternal HFD on 
the methylation status of hepatic lipid synthesizing genes. Timed-Pregnant Sprague-
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Dawley rats were exposed to either a HFD or C diet during gestation and lactation. The 
pups were weaned onto a HFD for 9 weeks. We then collected liver samples and ran 
qRT-PCR to check for differences in multiple metabolic pathways including glycolysis, 
gluconeogenesis, fatty acid synthesis, and triacylglycerol synthesis. We found differences 
in mRNA expression in both the fatty acid synthesis pathway and the triacylglycerol 
synthesis pathway. The two major enzymes that we found to be differentially expressed 
were FASN and GPAM. Upon further inspection of the methylation status on GPAM, we 
found differential methylation patterns along the gene body. 
In order to store fat in the liver, two major steps need to occur: fatty acid synthesis 
and triacylglycerol synthesis. ACC1 is the rate-limiting enzyme that converts acetyl-CoA 
into malonyl-CoA, which is the building block used to create fatty acids by the FASN 
enzyme. Through a serious of steps that involve GPAM, which is the rate-limiting enzyme 
in triacylglycerol synthesis, long-chain acyl-CoA is transferred onto a glycerol-3-
phosphate backbone eventually creating triacylglycerol [28]. Overexpression of these 
enzymes has been linked to hepatic lipid accumulation [2]. Since hepatic lipid 
accumulation is limited to either an increase in fatty acid and triacylglycerol synthesis or 
a decrease in beta oxidation or lipid export the mRNA expression data showed evidence 
of a possible physiological enzymatic mechanism. Since the mRNA expression data did 
not show any differences in the lipid export or beta oxidation pathways and the differential 
mRNA expression data shown in the fatty acid and triacylglycerol pathway show the 
decrease to occur in the C/HF group, the overload of dietary lipid influx is the most 
plausible explanation for the hepatic lipid accumulation. In the first model, we are working 
with mice that have presumably normal hepatic physiology as the maternal diets were 
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both C, therefore; it is not surprising that an intervention with a HFD would downregulate 
de novo hepatic lipogenesis. Since lipid export and beta oxidation were not upregulated 
to offset the large influx of dietary lipids, the disproportionate rate of lipid import to export 
and utilization is most likely to be the cause of the apparent hepatic lipid accumulation. It 
is important to note that the aim of this study was to find the role of methylation in hepatic 
lipid synthesizing genes. Our data suggest that this decrease in lipid synthesizing genes 
due to a post-weaning HFD is in a positive relationship with overall decreased gene 
methylation along the gene body of both ACC1 and GPAM. 
 In the second model, in which we looked at a maternal HFD, the HF/HF group 
showed an overexpression of FASN and GPAM, which provided us the physiological 
enzymatic mechanism for the apparent hepatic lipid accumulation. Since lipid 
accumulation requires an increase in available fatty acid and triacylglycerol production, 
the increase mRNA expression of FASN and GPAM provides the most plausible 
mechanism. The increased mRNA expression of GPAM was linked to an overall increase 
in gene body methylation; with no apparent differences in the promoter region of the gene. 
From the MEDIP-SEQ data, we were able to identify four different locations that showed 
increased methylation along the gene body for the HF/HF group, while the C/HF group 
only had one peak increase (Figures 4-9 & 4-10). 
 In order to validate the methylation patterns, we observed in the MEDIP-SEQ data, 
we performed a MSP with primers along six different locations on the gene body, which 
included both intronic and exonic positions. Although we saw increased methylation for 
the HF/HF group in all six locations, the following two specific locations showed a 
	 29	
significant increase for the HF/HF group: Intron 1 +7200 base pairs and Exon 21+59500 
base pairs (Figure 4-11). 
 These data suggest that the increase in mRNA expression is in concordance with 
an overall increase in gene body methylation. As shown in the literature review and our 
hypothesis, this seems to contradict the concept of increased methylation leading to 
decreased gene expression. However, a few studies did indeed show that even on 
promoter methylation, increased methylation leads to increased gene expression [1,5,8]. 
Aside from the few studies that show a positive relationship between gene expression 
and methylation and the majority studies that show a negative relationship, the status on 
gene body methylation is unclear; especially when looking at the effects of a HFD on 
hepatic metabolic pathways.  
 To highlight this uncertainty in the role of gene body methylation, an in vitro study 
done by Shenker et al., showed that in breast cancer cells that are estrogen receptor 
alpha positive (ESR1+) there is a significantly higher percentage of methylation along the 
gene body than in ESR- cells. More specifically, they found the following three locations 
along the gene body to have a significantly increased percentage of methylation: +38810, 
+150393, and +204185 base pairs from the TSS [16]. These data seem to suggest and 
confirm our own results in that increased gene body methylation leads to increased gene 
expression. Shenker et al. then treated those cells with a demethylating agent, decitabine, 
which did indeed significantly reduce methylation levels. When comparing the differences 
between the decitabine treated cells to the C cells within ESR1+ cells, there was indeed 
a decrease in ESR1 gene expression. However, when treating ESR1- cells with 
decitabine and significantly reducing gene body methylation there was a stark increase 
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in gene expression; almost 20-fold [16]. This apparent paradox does not make clear what 
the exact role is regarding gene body methylation. 
 Another in vitro study that adds more information to this picture shows that 
demethylating the gene body of TWIST1 in gastric cancer cells leads to an increase in its 
gene expression. More specifically, Sakamoto et al. were able to find that the methylation 
of the exon 1 region was linked to the silencing of the TWIST1 expression even more so 
than the methylation of its promoter [26]. Brenet et al. confirmed this same result using a 
genome-wide analysis of DNA methylation and gene expression. They concluded that the 
first region in exon 1 is more tightly linked to the silencing of the gene expression than 
even promoter methylation [27].   
These studies seem to suggest a significant role of gene body methylation in gene 
expression, as well as an apparent silencing role between the first exon and increased 
methylation. However, our study is the first to show increased methylation at the first 
intron and last exon in a positive relationship with mRNA expression for GPAM. Although 
we see a different metabolic physiology between similar enzymes due to the two 
inherently different models, the general gene body methylation patterns seem to maintain 
consistently in both models. Furthermore, our studies suggest that a HFD can either 
program or alter transcriptional gene expression of lipid synthesizing genes by altering 
gene body methylation in a positive relationship.  
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Tables & Figures 
 






















Table 4-1. mRNA Expression of Hepatic Metabolic Genes1,2 
 
1All values are means ± SEM, n=8. Bolded values indicate a statistical significance when 
compared to C/HF.
Gene Function Gene C/C C/HF HF/HF 
TF of PEPCK CEBPb 0.87 ± 0.131 1.17 ± 0.135 1.03 ± 0.085 
 SREBP1-c 0.66 ± 0.055 0.91 ± 0.104 1.01 ± 0.105 
GNG G6Pase 0.88 ± 0.176 0.40 ± 0.089 0.75 ± 0.152 
 FBP1 0.94 ± 0.161 0.82 ± 0.076 0.83 ± 0.065 
 PEPCK 0.71 ± 0.056 0.63 ± 0.060 0.68 ± 0.132 
Glycolysis PFK1 0.80 ± 0.057 0.89 ± 0.067 0.98 ± 0.056 
FA Synthesis ACC1 1.24 ± 0.118 0.54 ± 0.097 0.68 ± 0.064 
 FASN 0.62 ± 0.087 0.23 ± 0.049 0.47 ± 0.062 
FA Oxidation CPT1a 0.64 ± 0.067 0.86 ± 0.172 0.84 ± 0.072 
TAG Synthesis DGAT1 0.83 ± 0.081 0.71 ± 0.076 0.83 ± 0.066 
 GPAM 0.68 ± 0.136 0.29 ± 0.037 0.57 ± 0.056 
 AGPAT6 0.86 ± 0.065 0.88 ± 0.032 0.80 ± 0.051 
Lipid Export MTTP 1.13 ± 0.520 1.16 ±0.265 N/A 
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1Histological Assay Includes Oil Red O Staining and Quantification of Livers of Male 
Offspring Fed a HFD or C Diet. * Indicates a P-value < 0.05. 
Figure 4-1. A) Oil Red O Staining: Red Color Indicates Lipid Deposition. 















Figure 4-2. Average Methylation Read for Acetyl CoA Carboxylase 1: Promoter to 48 
kB1,2,3,4 
 
1Methylation Data obtained via MEDIP-SEQ-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 



























Figure 4-3. Average Methylation Reads for Acetyl CoA Carboxylase 1: 49-97 kB1,2,3,4 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 




























Figure 4-4. Average Methylation Reads for Acetyl CoA Carboxylase 1: 97.5-145.5 kB1,2,3,4 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 












































































































Figure 4-5. Average Methylation Reads for Acetyl CoA Carboxylase 1: 146-194 kB1,2,3,4,5 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 
4Blue Boxes Indicate a Running Count of Methylation Peak Increases for the C/C Group. 














































































































Figure 4-6. Average Methylation Reads for Glycerol-3-Phosphate Acyltransferase: TSS 
to 30 kB1,2,3,4,5 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 
4Blue Boxes Indicate a Running Count of Methylation Peak Increases for the C/C Group. 






























Figure 4-7. Average Methylation Reads for Glycerol-3-Phosphate Acyltransferase: 30.5-
59.5 kB1,2,3,4,5 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 
4Blue Boxes Indicate a Running Count of Methylation Peak Increases for the C/C Group. 




































1Histological Assays Including H&E Stain (A) and Oil Red O Stain (B) of Livers of Male 
Offspring of Rat Dams Fed a HFD or C Diet. 
2H&E Stain: White Circular Areas Indicate Hepatic Vacuolation 
3Oil Red O Stain: Red Circular Areas Indicate Lipid Deposition  






Figure 4-9. Average Methylation Reads for Glycerol-3-Phosphate Acyltransferase: TSS 
to 30 kB1,2,3,4 
 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 




Figure 4-10. Average Methylation Reads for Glycerol-3-Phosphate Acyltransferase: 30.5-
59.5 kB1,2,3,4,5 
 
1Methylation Data obtained via MEDIP-SEQ. 
2Red Box Indicates Background Noise of MEDIP-SEQ Technique: Values that Fall Under 
5 are Not Considered for Analysis. 
3Green Boxes Indicate Highlighted Differential Methylated Peak Regions. 
4Orange Box Indicates a Running Count of Methylation Peak Increase for the C/HF 
Group. 





























Figure 4-11. Methylation Levels Along Gene Body of GPAM1,2,3 
 
1All values are means ± SEM, n=9 for C/HF and n=7 for HF/HF. * indicates a P-value < 
0.05. 
2Data obtained via MSP. 
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